DNLI
Denali Therapeutics Inc
19.30$
-3.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 38.8% | -568.2% | 124.0% | -434.4% | -225.6% | -108.3% | – | – | |
| – | – | – | 5.7% | 30.0% | 2.5% | 17.7% | 9.6% | 5.1% | – | – | |
| – | – | – | 14.5% | 143.9% | 15.0% | 175.2% | 92.1% | 32.7% | – | – | |
| – | – | – | 14.5% | 142.5% | 15.0% | 187.0% | 87.5% | – | – | – | |
| – | – | – | 48.7% | 11.0% | 85.9% | -41.9% | -22.2% | -87.7% | – | – | |
| – | – | – | 2.6% | 67.2% | 0.9% | 17.5% | 16.4% | 3.9% | – | – | |
| – | – | – | -222.5% | 553.7% | -185.7% | -44.4% | -130.4% | 75.4% | – | – | |
| – | – | – | 2.0% | 23.2% | 63.9% | 39.8% | – | – | – | – | |
| – | – | – | – | – | – | – | 0.0% | 0.0% | – | – | |
| – | – | – | 75.1% | 23.2% | 189.1% | 39.8% | 286.4% | 5.4% | – | – | |
| – | – | – | -108.6% | 8.7% | 127.4% | -439.1% | -69.5% | -27.5% | – | – | |
| – | – | – | 36.2% | -635.3% | 123.1% | -451.9% | -242.1% | -112.2% | – | – |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.